GTX Corp Adds Rapid Diagnostic Test Kits for the SARS-COV-2 (COVID-19) Antigen
LOS ANGELES, CALIFORNIA – February 18, 2021 – GTX Corp (OTC: GTXO) (“GTX” or the “Company”), a pioneer in the field of wearable GPS human and asset tracking systems and a supplier of Health and Safety personal protective medical equipment “PPE”, announced today it has begun the distribution of a Rapid Diagnostic Test-Kits for Antigens. The highly accurate, 10-minute results COVID-19 Antigen test is approved under the Emergency Use Authorization (“EAU”) and tests for the detection of Antigens specific to SARS-CoV-2. The COVID-19 Antigen test (www.gtxmask.com) is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in nasopharyngeal swab specimens collected from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of symptom onset. Key Attributes of the Rapid Test Kit: Approved under the EAU act. Made in the U.S.A. Test results within 10 minutes. No Lab […]